Transcatheter Tech. touts no leakage at 6-months with Trinity TAVI

Transcatheter Technologies' touts zero instances of paravalvular leakage in 6-month pilot results for its Trinity transcatheter aortic valve implantation system.

Transcatheter Technologies GmbH touted 6-month results from a pilot study of its Trinity transcatheter aortic valve implantation system, reporting no instances of valve leakage.

Transcatheter Technologies GmbH

News Well, Clinical Trials, Cardiac Implants, Replacement Heart Valves

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/NP6bVe